Iovance Biotherapeutics (IOVA) Gives Update on Revenue Guidance, Lung Cancer Cure
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best stocks under $3 to invest in. On January 9, Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc. (IOVA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rhenman & Partners Asset Management Henrik Rhenman | 1,595,327 | $4,355,243 | +46% | 0.41% |
| 2. | Walleye Capital Will England | 822,754 | $2,246,118 | +2144% | 0.01% |
| 3. | QVT Financial Daniel Gold | 678,564 | $1,852,480 | 0.16% | |
| 4. | Renaissance Technologies Jim Simons | 651,000 | $1,777,230 | 0% | |
| 5. | 162,900 | $444,717 | +4303% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.84 | 30,000 | $55,200.00 | 30,000 | 2025-06-05 | Filing | |
| $1.74 | 5,600 | $9,743.44 | 206,852 | 2025-05-23 | Filing | |
| $1.69 | 25,000 | $42,250.00 | 374,646 | 2025-05-14 | Filing | |
| $9.15 | 250,000 | $2,287,500.00 | 320,150 | 2024-02-20 | Filing | |
| $9.15 | 32,000 | $292,800.00 | 54,000 | 2024-02-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.06 | 50,000 | $503,000.00 | 7,500 | 2024-11-12 | Filing | |
| $8.71 | 20,500 | $178,612.40 | 100,000 | 2016-08-25 | Filing | |
| $9.10 | 33,500 | $304,799.75 | 120,500 | 2016-08-24 | Filing | |
| $9.11 | 54,000 | $491,740.20 | 100,000 | 2016-08-22 | Filing | |
| $7.13 | 16,500 | $117,645.00 | 154,000 | 2015-09-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 29,518,125 | $80,584,481 | 0% | |
| 2. | 27,207,079 | $74,275,326 | 0% | |
| 3. | 20,161,445 | $55,040,745 | 0% | |
| 4. | 9,191,840 | $25,093,723 | 0% | |
| 5. | 8,607,564 | $23,498,650 | 0% |
News See All
11 Best Stocks Under $3 to Buy Right Now
In the stock market, stocks currently trading under $3 per share are typically small-cap stocks, defined as shares of publicly traded companies with a market capitalization between $300 million and $2...
Iovance Biotherapeutics, Inc. (IOVA): A Bull Case Theory
We came across a bullish thesis on Iovance Biotherapeutics, Inc. (IOVA) on r/biotech_stocks by u/DebtFit2132. In this article, we will summarize the bulls’ thesis on IOVA.
Barclays Adjusts Valuation Targets for Iovance Biotherapeutics (IOVA) Amid Biotech Sector Review
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best biotech penny stocks to buy according to analysts.
10 Best Biotech Penny Stocks to Buy According to Analysts
On December 24, Jared Holz of Mizuho joined 'Power Lunch' on CNBC to talk about how to play biotech moving into 2026.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2025 Earnings Call Transcript
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2025 Earnings Call Transcript November 6, 2025Iovance Biotherapeutics, Inc. beats earnings expectations.
Iovance Biotherapeutics, Inc. (IOVA) Targeting $1B on Amtagvi Sales amid Cost Cuts
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the best healthcare penny stocks to buy now. On September 9, at the H.C.
11 Best Healthcare Penny Stocks to Buy Now
The US healthcare sector is one of the biggest in the world, with spending expected to reach $5.3 trillion this year.
Top 10 Stocks Under $10 That Could Triple
The Bureau of Labor Statistics reported that only 22,000 jobs were added in August, much less than the 75,000 jobs that economists polled by Dow Jones had expected.
Artisan Small Cap Fund Exited Its Stake in Iovance Biotherapeutics (IOVA) Due to Operational Challenges
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center Billionaire Hedge Funds
